Hepatitis C elimination in the Netherlands (CELINE): Study protocol for nationwide retrieval of lost to follow-up patients with chronic hepatitis C

Background The Netherlands has a low hepatitis C virus (HCV) prevalence, estimated at 0.16%. Previous studies have shown that up to 30% of the diagnosed HCV population in the Netherlands has been lost to follow-up (LTFU). Retrieval of these patients could halt progression of liver disease in infected patients, reduce the number of infected individuals and limit HCV transmission. Several regional Dutch retrieval projects have already been executed, which demonstrated that retrieval is feasible. Therefore, we initiated a nationwide retrieval project, aiming to achieve microelimination in previou... Mehr ...

Verfasser: Isfordink, C.J. (Cas J)
Brakenhoff, S.M. (Sylvia M)
Van Dijk, M. (Marleen)
Valk, M. (Marc) van der
Knegt, R.J. (Robert) de
Arends, J.E. (Joop)
Drenth, J.P.H. (Joost)
Dokumenttyp: Artikel
Erscheinungsdatum: 2020
Schlagwörter: antiviral therapy / HCV / health service research / hepatitis C / infectious disease
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-29615621
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://repub.eur.nl/pub/126372

Background The Netherlands has a low hepatitis C virus (HCV) prevalence, estimated at 0.16%. Previous studies have shown that up to 30% of the diagnosed HCV population in the Netherlands has been lost to follow-up (LTFU). Retrieval of these patients could halt progression of liver disease in infected patients, reduce the number of infected individuals and limit HCV transmission. Several regional Dutch retrieval projects have already been executed, which demonstrated that retrieval is feasible. Therefore, we initiated a nationwide retrieval project, aiming to achieve microelimination in previously diagnosed but LTFU patients with chronic HCV through retrieval. Methods Laboratory records will be used to identify possible patients with chronic hepatitis C, defined as either a positive most recent HCV RNA or positive HCV antibodies without known RNA result. Reviewing patient records and obtaining current contact information from municipality databases will identify LTFU patients who are